GlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTD
people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
Nasdaq3d
Glucotrack, Inc. Announces First-in-Human Trial Data for Continuous Blood Glucose Monitoring System to be Presented at 2025 ATTD Conference
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
Nasdaq3d
Glucotrack To Present First-In-Human Results Of Continuous Blood Glucose Monitor At ATTD 2025
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
Yahoo Finance2d
GlucoTrack, Inc. (GCTK)
Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with ...
Yahoo Finance3d
GlucoTrack, Inc. (GCTK)
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technologyRUTHERFORD, N.J., Feb. 26, 2025 (GLOBE ...
Investing9d
Glucotrack finalizes equity securities sales
RUTHERFORD, NJ – Glucotrack, Inc. (NASDAQ:GCTK), a medical device company with a market capitalization of $3.54 million, disclosed the completion of several transactions involving unregistered ...
Benzinga.com26d
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
Glucotrack, Inc. GCTK reports it has achieved a significant milestone in its mission to transform diabetes management through three distinct advances: direct blood glucose measurement, hassle-free ...
Investing9d
Glucotrack finalizes equity securities sales
RUTHERFORD, NJ – Glucotrack, Inc. (NASDAQ:GCTK), a medical device company with a market capitalization of $3.54 million, disclosed the completion of several transactions involving unregistered sales ...
The Globe and Mail25d
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
DETROIT, MICHIGAN - February 25, 2025 (NEWMEDIAWIRE) - Glucotrack, Inc. (NASDAQ: GCTK) reports it has achieved a significant milestone in its mission to transform diabetes management through three ...
Yahoo Finance24d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
Morningstar24d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...